LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | PF431396 | 0.37 | uM | LJP5 | 72 | hr | 658 | 1815 | 3846 | 0.4719 | 0.3629 |
Hs 578T | PF477736 | 0.37 | uM | LJP5 | 72 | hr | 658 | 759 | 3846 | 0.1975 | 0.0318 |
Hs 578T | PF562271 | 0.37 | uM | LJP6 | 72 | hr | 658 | 2778 | 3846 | 0.7223 | 0.6650 |
Hs 578T | PHA-665752 | 0.37 | uM | LJP5 | 72 | hr | 658 | 3966 | 3846 | 1.0313 | 1.0378 |
Hs 578T | PHA-793887 | 0.37 | uM | LJP6 | 72 | hr | 658 | 891 | 3846 | 0.2317 | 0.0730 |
Hs 578T | PI103 | 0.37 | uM | LJP6 | 72 | hr | 658 | 1504 | 3846 | 0.3912 | 0.2655 |
Hs 578T | PLX-4720 | 0.37 | uM | LJP5 | 72 | hr | 658 | 4100 | 3846 | 1.0662 | 1.0798 |
Hs 578T | QL-X-138 | 0.37 | uM | LJP6 | 72 | hr | 658 | 2378 | 3846 | 0.6184 | 0.5396 |
Hs 578T | QL-XII-47 | 0.37 | uM | LJP6 | 72 | hr | 658 | 1963 | 3846 | 0.5104 | 0.4093 |
Hs 578T | Radicicol | 0.37 | uM | LJP5 | 72 | hr | 658 | 1688 | 3846 | 0.4389 | 0.3230 |
Hs 578T | Radicicol | 0.37 | uM | LJP6 | 72 | hr | 658 | 1309 | 3846 | 0.3403 | 0.2042 |
Hs 578T | Seliciclib | 0.37 | uM | LJP5 | 72 | hr | 658 | 3790 | 3846 | 0.9854 | 0.9824 |
Hs 578T | Ruxolitinib | 0.37 | uM | LJP5 | 72 | hr | 658 | 3683 | 3846 | 0.9576 | 0.9488 |
Hs 578T | XL147 | 0.37 | uM | LJP5 | 72 | hr | 658 | 3928 | 3846 | 1.0215 | 1.0259 |
Hs 578T | Saracatinib | 0.37 | uM | LJP6 | 72 | hr | 658 | 3112 | 3846 | 0.8091 | 0.7697 |
Hs 578T | Selumetinib | 0.37 | uM | LJP6 | 72 | hr | 658 | 1976 | 3846 | 0.5139 | 0.4135 |
Hs 578T | Sirolimus | 0.37 | uM | LJP6 | 72 | hr | 658 | 2424 | 3846 | 0.6303 | 0.5540 |
Hs 578T | Sorafenib | 0.37 | uM | LJP6 | 72 | hr | 658 | 4009 | 3846 | 1.0425 | 1.0513 |
Hs 578T | SU11274 | 0.37 | uM | LJP5 | 72 | hr | 658 | 3698 | 3846 | 0.9616 | 0.9536 |
Hs 578T | Fedratinib | 0.37 | uM | LJP5 | 72 | hr | 658 | 3225 | 3846 | 0.8385 | 0.8052 |
Hs 578T | TGX221 | 0.37 | uM | LJP5 | 72 | hr | 658 | 3599 | 3846 | 0.9358 | 0.9225 |
Hs 578T | Torin1 | 0.37 | uM | LJP6 | 72 | hr | 658 | 1069 | 3846 | 0.2779 | 0.1289 |
Hs 578T | Torin2 | 0.37 | uM | LJP5 | 72 | hr | 658 | 522 | 3846 | 0.1359 | -0.0425 |
Hs 578T | Tozasertib | 0.37 | uM | LJP5 | 72 | hr | 658 | 789 | 3846 | 0.2051 | 0.0410 |
Hs 578T | Trametinib | 0.37 | uM | LJP5 | 72 | hr | 658 | 891 | 3846 | 0.2317 | 0.0730 |